Efficacy and Safety of Tofacitinib in Patients with Ankylosing Spondylitis by Baseline BMI: A Post Hoc Analysis of Phase 2 and Phase 3 Trials

被引：0
|
作者：
Norton, Hillary [1 ]
Sliwinska-Stanczyk, Paula [2 ]
Hala, Tomas [3 ]
Elzorkany, Bassel [4 ]
Stockert, Lori [5 ]
Shi, Harry [5 ]
Wang, Cunshan [6 ]
Paulissen, Jerome [7 ]
Ritchlin, Christopher [8 ]
机构：
[1] Sante Fe Rheumatol, Santa Fe, NM USA
[2] Reumatika Ctr Reumatol, Warsaw, Poland
[3] Ctr Clin & Basic Res, Pardubice, Czech Republic
[4] Cairo Univ, Dept Rheumatol, Cairo, Egypt
[5] Pfizer Inc, Collegeville, PA USA
[6] Pfizer Inc, Groton, CT USA
[7] Pfizer Inc, New York, NY USA
[8] Univ Rochester, Allergy Immunol & Rheumatol Div, Sch Med, Canandaigua, NY USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0405
引用
收藏
页码：800 / 803
页数：4
相关论文
共 50 条
  • [1] Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis by Baseline C-Reactive Protein Level: Post Hoc Analysis of Phase II and Phase III Clinical Trials
    Deodhar, Atul
    Baraliakos, Xenofon
    Magrey, Marina
    Gensler, Lianne S.
    Thorat, Amit, V
    Pemmaraju, Surya Kiran
    Cadatal, Mary Jane
    Nash, Peter
    [J]. JOURNAL OF RHEUMATOLOGY, 2024, 51 (08) : 772 - 780
  • [2] TOFACITINIB EFFICACY AND SAFETY IN PATIENTS WITH ANKYLOSING SPONDYLITIS BY BASELINE C-REACTIVE PROTEIN LEVELS: A POST HOC ANALYSIS
    Deodhar, A.
    Baraliakos, X.
    Magrey, M.
    Gensler, L. S.
    Thorat, A. V.
    Kinch, C.
    Pemmaraju, S.
    Cadatal, M. J.
    Nash, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1685 - 1686
  • [3] Tofacitinib Efficacy and Safety in Patients with Ankylosing Spondylitis by Baseline C-Reactive Protein Levels: A Post Hoc Analysis
    Deodhar, Atul
    Baraliakos, Xenofon
    Magrey, Marina Nighat
    Gensler, Lianne
    Thorat, Amit V.
    Pemmaraju, Surya
    Cadatal, Mary Jane
    Nash, Peter
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1012 - 1014
  • [4] Efficacy and Safety of Tofacitinib in Patients with Ankylosing Spondylitis by Prior bDMARD Treatment: Analysis of a Phase 3 Trial
    Deodhar, Atul
    Marzo-Ortega, Helena
    Wu, Joseph
    Wang, Cunshan
    Dina, Oluwaseyi
    Kanik, Keith S.
    Fallon, Lara
    Gensler, Lianne
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 840 - 843
  • [5] Site-Specific Responses of Joint and Entheses to Tofacitinib in Patients with Ankylosing Spondylitis: A Post Hoc Analysis of a Phase 3 Trial
    Micheroli, Raphael
    Killeen, Tim
    Jo, Hyejin
    Kwok, Kenneth
    Elzorkany, Bassel
    Ospelt, Caroline
    Ciurea, Adrian
    Nissen, Michael
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 799 - 800
  • [6] Impact of Race on the Efficacy and Safety of Tofacitinib in Patients with RA: A Post Hoc Analysis of Phase 2, 3, and 3b/4 Clinical Trials
    Wright, Grace
    Mysler, Eduardo
    Chen, Yi-Hsing
    Kinch, Cassandra
    Yndestad, Arne
    Kwok, Kenneth
    Cadatal, Mary Jane
    Germino, Rebecca
    Ogdie, Alexis
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3495 - 3498
  • [7] Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials
    John Tesser
    Ahmet Gül
    Ewa Olech
    Kurt Oelke
    Tatjana Lukic
    Kenneth Kwok
    Abbas Ebrahim
    [J]. Arthritis Research & Therapy, 25
  • [8] Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials
    Tesser, John
    Gul, Ahmet
    Olech, Ewa
    Oelke, Kurt
    Lukic, Tatjana
    Kwok, Kenneth
    Ebrahim, Abbas
    [J]. ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [9] IMPACT OF RACE ON THE EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF PHASE 2, 3 AND 3B/4 CLINICAL TRIALS
    Wright, G. C.
    Mysler, E.
    Chen, Y. H.
    Kinch, C.
    Yndestad, A.
    Kwok, K.
    Cadatal, M. J.
    Germino, R.
    Ogdie, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 609 - 609
  • [10] SEX DIFFERENCES IN THE EFFICACY AND SAFETY OF TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS: A POST HOC ANALYSIS OF PHASE 3 AND LONG-TERM EXTENSION TRIALS
    Jones, H. N.
    Strand, V.
    Schulze-Koops, H.
    Mysler, E.
    Kinch, C.
    Gruben, D. C.
    Germino, R.
    Connell, C. A.
    Eder, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 565 - 566
12345